Wang L, Yang H M, Zhao Z Z
Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing.
Yao Xue Xue Bao. 1994;29(6):427-32.
Tai-Ding-An (3-phthalimido-2-oxo-n-butyraldehyde bisthiosemicarbazone, TDA) is a synthetic antiviral drug developed by our institute. Because of its low water/lipid solubility. Tai-Ding-An is limited to topical treatment of herpes viruses infected skin diseases and of condylomata acuminata (ginital warts), one of sexual transmitted diseases (STD), caused by human papilloma virus (HPV). Ten TDA derivatives IIIb-e, Va, Vb, VIIa-e have been synthesized in order to search for compounds with higher antiviral activity and better solubility than the parent compound as well as to explore structure and activity relationship. Among the ten analogs, three compounds (IIIc, VIIa and VIIb) were found to be effective against herpes simplex virus. The most potent inhibitor was 3-phthalimido-2-oxo-n-butyraldehyde bis- N4- phenylthiosemicarbazone (IIIc, PTDA) which was approximately 10 times more active against HSV-2 as compared with TDA. Compound IIIc was also found to be effective on the topical treatment of herpetic epithelial keratitis in rabbits.
泰定安(3-邻苯二甲酰亚氨基-2-氧代正丁醛双硫代半卡巴腙,TDA)是由本研究所研发的一种合成抗病毒药物。由于其水/脂溶性较低,泰定安仅限于局部治疗由疱疹病毒感染引起的皮肤病以及由人乳头瘤病毒(HPV)引起的性传播疾病之一尖锐湿疣(生殖器疣)。为了寻找比母体化合物具有更高抗病毒活性和更好溶解性的化合物,并探索结构与活性的关系,已合成了10种TDA衍生物IIIb - e、Va、Vb、VIIa - e。在这10种类似物中,发现有3种化合物(IIIc、VIIa和VIIb)对单纯疱疹病毒有效。最有效的抑制剂是3-邻苯二甲酰亚氨基-2-氧代正丁醛双-N4-苯基硫代半卡巴腙(IIIc,PTDA),其对HSV-2的活性比TDA高约10倍。还发现化合物IIIc对兔疱疹性上皮性角膜炎的局部治疗有效。